Animal Blood Bank Market Size & Growth Forecast 2027–2036, By Segments (Product, Type, Species, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Animal Blood Bank Market size stood at USD 1.79 billion in 2026 and is predicted to grow at a 9.01% CAGR from 2027 to 2036, surpassing USD 4.24 billion by 2036. The industry revenue for 2027 is estimated at USD 1.93 billion.
Get more details on this report
Request Free Sample ReportAnimal Blood Bank Market Intelligence Snapshot
Regional Market Dynamics
- North America held 52.22% of the market in 2026, supported by established veterinary hospitals, advanced transfusion practices, rising pet ownership, and demand for reliable blood products in emergency and surgical care.
- Expanding veterinary hospital networks, rising companion animal ownership, and increasing investment in specialized care are driving demand for organized blood collection, preservation, and transfusion services.
Segment Momentum
- Packed red blood cells held a 48.76% market share in 2026, supported by their essential role in treating anemia, trauma, blood loss, and surgical cases requiring targeted red blood cell replacement.
- Plasma is the fastest-growing product segment, supported by increasing demand for coagulation support, plasma protein replacement, and bleeding management in complex surgeries, trauma care, and critical veterinary cases.
Market Expansion Drivers
- Rising demand for veterinary care and blood transfusion services.
- Growth in pet ownership and animal health awareness.
- Development of advanced blood storage and transfusion technologies.
Leading Market Participants
- Top players in the animal blood bank market include Dechra (UK), Zoetis (USA), Bayer (Germany), IDEXX (USA), Merck (USA), Elanco (USA), Boehringer Ingelheim (Germany), Hematech (USA), Vetblood (Canada), Phoenix Bio (Japan).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.79 billion
- 2027 Estimated Market Size: USD 1.93 billion
- Projected Market Size: USD 4.24 billion by 2036
- Growth Forecast: 9.01% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Product (Packed Red Blood Cells) | Type (Standalone) | Species (Canine) | End-use (Hospitals & Clinics)
- Emerging Opportunity Segment: Product (Plasma) | Type (Standalone) | Species (Feline) | End-use (Hospitals & Clinics)
Market Growth Drivers and Industry Trends
Rising demand for veterinary care and blood transfusion services
The growth of the animal blood bank market is driven by the rising demand for advanced veterinary care and blood transfusion services. Veterinary hospitals and specialty clinics are increasingly managing complex surgeries, trauma cases, severe anemia, blood disorders, and other conditions that require timely access to blood products. The availability of screened and appropriately stored blood components supports faster intervention and improves the ability of veterinarians to manage critical cases. This growing emphasis on specialized treatment is strengthening the need for organized animal blood banking services.
Growth in pet ownership and animal health awareness
The growth of the animal blood bank market is attributed to increasing pet ownership and greater awareness of animal health and preventive care. Pet owners are becoming more attentive to advanced diagnostic and therapeutic options and are increasingly willing to seek specialized treatment for serious medical conditions. This shift is encouraging veterinary practices to expand their capabilities for emergency care, surgery, and complex disease management. As awareness of transfusion-based treatment options improves, demand for reliable access to veterinary blood products is also increasing.
Development of advanced blood storage and transfusion technologies
The growth of the animal blood bank market is supported by advancements in blood collection, processing, storage, compatibility testing, and transfusion technologies. Improved preservation methods help maintain the quality and safety of blood components, while enhanced screening and monitoring processes support more reliable transfusion practices. Advances in veterinary transfusion protocols are also enabling broader use of blood products across emergency and specialized care settings. These developments are strengthening the infrastructure required for efficient collection and distribution of animal blood products.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for veterinary care and blood transfusion services | 3% | Short term (≤ 2 yrs) | North America; Europe; Spillover: Asia Pacific | Medium | Fast |
| Growth in pet ownership and animal health awareness | 2.5% | Medium term (2–5 yrs) | Asia Pacific; North America; Spillover: Europe | Low | Moderate |
| Development of advanced blood storage and transfusion technologies | 3% | Long term (5+ yrs) | Europe; North America; Spillover: Asia Pacific | Medium | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for 52.22% share in 2026, maintaining its position as the largest regional market for animal blood banks, backed by well-developed veterinary healthcare infrastructure, increasing adoption of advanced veterinary treatment, and growing awareness of specialized blood transfusion services for companion and livestock animals. The region benefits from the presence of established veterinary hospitals, specialty clinics, diagnostic centers, and animal healthcare facilities that increasingly require reliable access to blood and blood products for emergency care, surgery, trauma management, and treatment of complex medical conditions. Rising pet ownership and greater willingness among animal owners to pursue advanced medical interventions are also supporting demand for organized blood banking services. Furthermore, improvements in veterinary diagnostics, transfusion medicine, blood collection practices, storage systems, and donor management are strengthening the overall animal blood supply ecosystem. Increasing attention toward emergency preparedness and the availability of compatible blood products is further encouraging veterinary institutions to establish structured procurement and transfusion protocols, supporting continued market development across the region.
Asia Pacific (Fastest-Growing Region)
The Asia Pacific animal blood bank market is experiencing rapid growth, driven by improving veterinary healthcare infrastructure, rising companion animal ownership, increasing awareness of advanced animal medical treatment, and the gradual development of organized veterinary blood collection and transfusion systems. Expanding veterinary hospital networks and growing access to specialized animal healthcare are increasing the need for dependable blood products, particularly for surgical procedures, trauma cases, anemia management, and critical care. In addition, improving economic conditions and greater expenditure on companion animal health are encouraging pet owners to seek sophisticated treatment options that were previously less accessible. Governments, veterinary institutions, and animal healthcare organizations are also placing greater emphasis on improving diagnostic and treatment capabilities, creating favorable conditions for the development of veterinary transfusion services. Moreover, increasing adoption of modern blood collection, preservation, compatibility testing, and storage practices is helping establish a more reliable supply chain for animal blood products, supporting the region's accelerated market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Veterinary Transfusion InfrastructureThe U.S. animal blood bank market is supported by advanced veterinary hospitals, emergency care, and growing demand for transfusion services in companion animals. Priorities include reliable blood-component availability, donor recruitment, storage infrastructure, and standardized veterinary transfusion practices across referral and specialty-care networks.
Germany 🇩🇪
Structured Veterinary Blood SupplyGermany emphasizes reliable veterinary transfusion services supported by organized donor programs, veterinary hospitals, and specialist care. Market priorities include maintaining dependable supplies of canine and feline blood products, improving storage and logistics, and strengthening clinical protocols for transfusion-dependent animals.
Japan 🇯🇵
Companion Animal Transfusion AccessJapan's animal blood bank market is closely linked to sophisticated companion-animal healthcare and increasing demand for emergency and surgical transfusion support. Priorities include expanding donor networks, improving blood-product availability, and strengthening distribution capabilities for veterinary clinics and advanced animal hospitals.
South Korea 🇰🇷
Veterinary Blood Supply ExpansionSouth Korea is developing veterinary transfusion capabilities alongside increasingly sophisticated companion-animal medical services. Market priorities include dependable donor recruitment, blood typing and component availability, and stronger supply coordination to support emergency treatment, surgery, trauma care, and specialty veterinary practices.
France 🇫🇷
Veterinary Donor Network DevelopmentFrance's animal blood bank market depends on organized veterinary donor networks and specialist clinics to support transfusion requirements. Priorities include maintaining adequate supplies of species-specific blood products, improving donor participation, and strengthening collection, storage, and distribution practices for emergency and elective procedures.
Italy 🇮🇹
Veterinary Transfusion CapabilityItaly is strengthening veterinary transfusion services through specialist animal hospitals and organized donor activity. Market priorities include improving access to compatible blood products, expanding canine and feline donor pools, and developing dependable collection and storage systems for emergency, surgical, and critical-care applications.
Animal Blood Bank Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Packed Red Blood Cells (Largest Segment) vs Plasma (Fastest-Growing Segment)
The packed red blood cells segment accounted for the largest share of 48.76% in the animal blood bank market in 2026, supported by its critical role in treating veterinary patients experiencing blood loss, anemia, trauma, and conditions requiring restoration of oxygen-carrying capacity. Packed red blood cells provide concentrated red cell components while limiting unnecessary plasma administration, making them particularly valuable when targeted red blood cell replacement is required. Their use across emergency care, surgical procedures, and treatment of chronic or acute blood disorders contributes to consistent demand from veterinary hospitals and specialized animal healthcare facilities. Growing awareness of component-based transfusion practices and improvements in veterinary transfusion medicine are further supporting the use of packed red blood cells as an essential blood product.
The plasma segment is expected to grow at the fastest pace over the forecast period, driven by its expanding application in veterinary patients requiring coagulation support, plasma protein replacement, and management of conditions associated with bleeding or impaired clotting. Plasma contains multiple proteins and coagulation factors, allowing it to serve a broader therapeutic purpose beyond red blood cell replacement. Its growing use in complex surgeries, trauma care, and critical veterinary cases is encouraging greater adoption of plasma-based transfusion therapy. Improvements in blood component separation, storage practices, and veterinary transfusion protocols are also supporting wider availability and utilization, while increasing recognition of targeted blood component therapy is creating additional opportunities for plasma demand.
Type Segment Analysis: Standalone (Largest & Fastest-Growing Segment)
The standalone type segment represents the largest segment of the animal blood bank market in 2026 and is also expected to grow at the fastest pace over the forecast period. Standalone animal blood banks provide dedicated infrastructure for collecting, processing, storing, and distributing blood and blood components for veterinary applications. Their specialized operating model enables greater focus on donor management, blood component quality, storage conditions, and timely availability for veterinary patients. The need for dependable access to compatible blood products during emergencies and planned procedures is encouraging veterinary providers to rely on dedicated blood banking infrastructure. Increasing specialization in veterinary healthcare, rising demand for transfusion services, and greater emphasis on maintaining reliable inventories of animal blood products are expected to support continued expansion of standalone facilities.
Species Segment Analysis: Canine (Largest Segment) vs Feline (Fastest-Growing Segment)
The canine segment accounted for the largest share of the animal blood bank market in 2026, reflecting the broad need for transfusion support in dogs across emergency medicine, surgery, trauma care, anemia management, and treatment of blood-related disorders. Dogs are frequently treated for conditions that may require blood component therapy, creating sustained demand for compatible canine blood products. The growing sophistication of veterinary hospitals and increasing adoption of advanced diagnostic and surgical procedures are also expanding the need for reliable canine transfusion resources. In addition, improved awareness of veterinary blood donation and component-based transfusion practices is supporting the development of more organized canine blood supply systems.
The feline segment is anticipated to register the fastest growth over the forecast period as veterinary practices increasingly recognize the importance of specialized transfusion support for cats. Feline patients may require blood products during trauma, surgery, severe anemia, and other critical conditions, while the need for appropriate blood-type matching places greater emphasis on organized feline donor and blood banking systems. Improvements in feline diagnostics, emergency care, and transfusion medicine are increasing the ability of veterinary providers to identify and manage cases requiring blood component therapy. Greater awareness of feline blood compatibility and the expansion of specialized veterinary services are expected to encourage broader adoption of feline blood banking solutions.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Packed Red Blood Cells, Whole Blood, Plasma, Others | Packed Red Blood Cells | Plasma |
| Type | Standalone, Institution-attached | Standalone | Standalone |
| Species | Canine, Feline, Others | Canine | Feline |
| End-use | Hospitals & Clinics, Academic & Research Institutions, Others | Hospitals & Clinics | Hospitals & Clinics |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Reliability of supply is a defining competitive factor in the animal blood bank market, where timely access to compatible, high-quality blood products can be critical for veterinary emergencies and surgical procedures. Strong donor networks, appropriate health screening, and geographically accessible sourcing help providers maintain inventory across species and blood types. Equally important is the ability to process donations into clinically appropriate components while maintaining product quality through validated storage, traceability, and inventory rotation practices. Distribution capabilities further distinguish providers, particularly when veterinary facilities require urgent deliveries without compromising product integrity. Although specialized equipment, quality control, and emergency logistics add operating costs, coordinated donor recruitment, processing, storage, and delivery can improve resource utilization and service dependability. Providers must balance broad clinical coverage with the practical constraints of donor availability and inventory management.
Major players in the animal blood bank market:
- Dechra (UK)
- Zoetis (USA)
- Bayer (Germany)
- IDEXX (USA)
- Merck (USA)
- Elanco (USA)
- Boehringer Ingelheim (Germany)
- Hematech (USA)
- Vetblood (Canada)
- Phoenix Bio (Japan)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Dechra (UK) | |||||||
| Zoetis (USA) | |||||||
| Bayer (Germany) | |||||||
| IDEXX (USA) | |||||||
| Merck (USA) | |||||||
| Elanco (USA) | |||||||
| Boehringer Ingelheim (Germany) | |||||||
| Hematech (USA) | |||||||
| Vetblood (Canada) | |||||||
| Phoenix Bio (Japan) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Department of Animal Husbandry and Dairying (DAHD) | August 2025 | The Department of Animal Husbandry and Dairying released comprehensive guidelines covering animal blood transfusion and veterinary blood banks, with emphasis on biosafety and state-regulated blood bank infrastructure. The framework provides a standardized basis for developing veterinary blood banking capabilities and supporting future innovations in animal transfusion practices across India. |
| Hope for Critters | May 2025 | Hope for Critters launched a canine blood donor program in Chennai to develop a database of canine blood donors and address shortages affecting pets requiring transfusions. The initiative is designed to connect potential donors with veterinary hospitals, strengthening access to timely canine blood transfusion resources and supporting the development of organized donor networks. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Animal Blood Bank Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Blood Sourcing Model | Volunteer/Community Donor Model, Replacement Donor Model, Commercial Donor Model |
| Blood Component Processing | Whole-Blood Processing, Red Blood Cell Component Processing, Plasma Component Processing |
| Blood Screening Technology | Serological Screening, Molecular Screening, Combined Serological & Molecular Screening |
Animal Blood Bank Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Veterinary Transfusion Adoption Pathways |
|
| Blood Donor Program Models |
|
| Veterinary Blood Supply Resilience |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How much revenue does the animal blood bank market generate?
What is the forecasted size of the animal blood bank industry?
How is the expansion of advanced veterinary care driving demand for animal blood banking?
How are pet health awareness and transfusion technology improving animal blood bank adoption?
Why do packed red blood cells account for the largest share of the animal blood bank market?
What is driving growth in the plasma segment of the animal blood bank market?
What makes North America the leading market for animal blood bank services?
Why is Asia Pacific experiencing rapid growth in the animal blood bank market?
Which companies are driving growth in the animal blood bank landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook